Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order

Fed Regist. 2011 Oct 21;76(204):65371-5.

Abstract

The Administrator of the Drug Enforcement Administration (DEA) is issuing this final order to temporarily schedule three synthetic cathinones under the Controlled Substances Act (CSA) pursuant to the temporary scheduling provisions of 21 U.S.C. 811(h). The substances are 4-methyl-N-methylcathinone (mephedrone), 3,4-methylenedioxy-N-methylcathinone (methylone), and 3,4-methylenedioxypyrovalerone (MDPV). This action is based on a finding by the Administrator that the placement of these synthetic cathinones and their salts, isomers, and salts of isomers into Schedule I of the CSA is necessary to avoid an imminent hazard to the public safety. As a result of this order, the full effect of the CSA and its implementing regulations including criminal, civil and administrative penalties, sanctions and regulatory controls of Schedule I substances will be imposed on the manufacture, distribution, possession, importation, and exportation of these synthetic cathinones.

MeSH terms

  • Alkaloids / adverse effects
  • Alkaloids / classification*
  • Benzodioxoles / adverse effects
  • Benzodioxoles / classification*
  • Central Nervous System Stimulants / adverse effects
  • Central Nervous System Stimulants / classification*
  • Designer Drugs / adverse effects
  • Designer Drugs / classification*
  • Drug Labeling / legislation & jurisprudence
  • Drug Packaging / legislation & jurisprudence
  • Drug and Narcotic Control / legislation & jurisprudence*
  • Humans
  • Methamphetamine / adverse effects
  • Methamphetamine / analogs & derivatives
  • Methamphetamine / classification*
  • Psychotropic Drugs / adverse effects
  • Psychotropic Drugs / classification*
  • Pyrrolidines / adverse effects
  • Pyrrolidines / classification*
  • Substance-Related Disorders
  • United States

Substances

  • Alkaloids
  • Benzodioxoles
  • Central Nervous System Stimulants
  • Designer Drugs
  • Psychotropic Drugs
  • Pyrrolidines
  • Methamphetamine
  • cathinone